Stocks: what is moving

• Aurobindo Pharma

  ▲ bullish +100%2 stories2 reportsAUROPHARMA +0.3%

  

  Aurobindo Pharma gets USFDA final approval for Perampanel tablets

  1 source · 3h

  • USFDA granted final approval for Aurobindo Pharma’s Perampanel tablets
  • Aurobindo plans to launch in Q3 FY27; estimated US market size is $67 million
  • The approval and launch plan could support Aurobindo Pharma’s US generics business
  1. ▲Aurobindo Pharma: Strong dose of growth opportunities1 source · 20m
  Open Aurobindo Pharma →
• Radico Khaitan

  ▲ bullish +100%1 story1 reportRADICO −3.0%

  

  How Radico Khaitan is building Indian luxury spirits through provenance, innovation and premiumisation

  1 source · 25m

  • Radico Khaitan is expanding premium spirits beyond single malt whisky into rum, gin, world malt and liqueurs
  • Premiumisation supports Radico Khaitan’s growth outlook in Indian alcoholic beverages
  Open Radico Khaitan →
• Titan Company

  ▲ bullish +100%1 story1 reportTITAN −1.6%

  

  Titan Company deepens focus on mechanical horology as category grows almost 5-fold

  1 source · 1h

  • Titan launched Vetra to build capabilities across mechanical watch functions and propositions
  • Titan’s investment in mechanical horology could support growth in its watches business
  Open Titan Company →
• Dr Reddy's

  ● mixed ±0%1 story1 reportDRREDDY −2.2%

  

  Dr Reddy’s US arm faces $32,350 IRS penalty over fiscal year misclassification

  1 source · 1h

  • Dr Reddy’s US arm faces a $32,350 IRS penalty over fiscal-year misclassification
  • Dr Reddy’s says the penalty has no material operational or financial impact
  Open Dr Reddy's →
• Lennar

  ● mixed ±0%1 story1 report

  Berkshire buys more Lennar shares, but pace of purchases slows

  1 source · 4h

  • Berkshire Hathaway raised its Lennar stake to 11.2%
  • The pace of Berkshire’s Lennar purchases appears to be slowing
  Open Lennar →
• Sobha

  ▲ bullish +100%1 story2 reportsSOBHA −0.7%

  

  Sobha Q2 business update: Bengaluru developer's total sales value rises 16% YoY to ₹2,206 crore

  1 source · 5h

  • Q2 FY27 sales value rose 16% YoY to ₹2,206 crore, but fell 40% sequentially
  • Sales area increased 2.2% YoY and declined 39.3% QoQ
  • Sobha’s sales growth supports sentiment for Indian residential real estate
  Open Sobha →
• Hindustan Zinc

  ▲ bullish +100%1 story1 reportHINDZINC −1.9%

  

  Hindustan Zinc Q2 business update: Refine lead production jumps 14%, check here for more

  1 source · 6h

  • Mined metal production rose 5% YoY to 271 kilotonnes; saleable metal output increased 7% to 264 kilotonnes
  • Refined lead production jumped 14%
  • Higher output may support Hindustan Zinc’s revenue and sentiment for Indian metal producers
  Open Hindustan Zinc →
• TVS Motor

  ● mixed ±0%1 story2 reportsTVSMOTOR −2.1%

  TVS Sales Sep 2026 - 2W 6.46 Lakh, CY Q3 19.19 Lakh Total

  2 sources · 15h

  Open TVS Motor →
• Orkla India

  ● mixed ±0%1 story1 reportORKLAINDIA −1.1%

  

  The spice of the matter

  1 source · 21m

  • Orkla India’s heritage brands face input-cost, volume and distribution tests as double-digit revenue growth returns
  • Orkla India investors face execution risks from costs, volumes and distribution
  Open Orkla India →
• The Federal Bank

  ● mixed ±0%1 story1 reportFEDERALBNK +0.3%

  

  F&O Strategy: Long strangle on Federal Bank

  1 source · 35m

  Open The Federal Bank →
• Nifty and Sensex

  ▼ bearish −33%2 stories3 reportsNifty 50 −0.9%

  

  New-Age Tech Stocks Extend Slide, Turtlemint Slumps Another 20% This Week

  1 source · 3h

  • 47 new-age tech stocks declined this week as benchmark indices logged an eighth consecutive weekly slide
  • Turtlemint fell another 20% this week
  • Continued weakness puts pressure on Indian new-age tech stocks, including Turtlemint
  All 2 stories →
• Nvidia

  ● mixed ±0%1 story3 reports

  

  Nvidia Hits First Record Since May As Value Nears $6 Trillion

  3 sources · 1d

  • Nvidia shares gained 2.9% Friday, extending a nearly 25% rally from a late-July low
  Open Nvidia →
• Pharma and healthcare

  ▲ bullish +100%2 stories2 reportsPharma −0.5%

  

  Aurobindo Pharma: Strong dose of growth opportunities

  1 source · 20m

  1. ▲Aurobindo Pharma gets USFDA final approval for Perampanel tablets1 source · 3h
  Open Pharma and healthcare →